Bronchiolitis is a viral-induced lower respiratory tract infection that mainly occurs in children <1 year of age.
Seasonality
In South Africa bronchiolitis peaks in the RSV season, which varies slightly by province. RSV circulation is evident from February through to June, before the influenza season (MaySeptember).
Diagnosis Clinical manifestations
Bronchiolitis is diagnosed on the basis of clinical signs and symptoms. In a young child, the clinical pattern of wheezing and hyperinflation is diagnostic and typically starts with an upper respiratory prodrome including rhinorrhoea, low-grade fever, cough and poor feeding, followed 1 -2 days later by tachypnoea, hyperinflation and wheeze as a consequence of airway inflammation and air trapping. The most reliable clinical feature of bronchiolitis is hyperinflation of the chest.
The illness is generally self-limiting but may progress to more severe disease.
Measurement of the peripheral arterial oxygen saturation is useful to indicate the need for supplemental oxygen. A saturation of <92% at sea level and <90% inland indicates that the child requires admission to hospital for supplemental oxygen.
Investigations
Chest X-rays are generally unhelpful and are not required in children with a clear clinical diagnosis of bronchiolitis. Haematological testing is not routinely required. Nasopharyngeal aspirates should not be routine, as viral testing adds little to routine management.
Management of bronchiolitis
Management is largely supportive. There is currently no proven effective therapy other than oxygen for hypoxic children (evidence A -well-designed randomised controlled clinical trial or diagnostic studies on relevant well-chosen populations), who can be given humidified low-flow oxygen (0.5 -3 L/min) by nasal prongs. There is no evidence for routine use of antibiotics, nebulised agents (including bronchodilators, adrenaline, steroids or hypertonic saline), oral steroids, chest physiotherapy or montelukast (evidence A).
